登录

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.

Such synergistic combinations of antibiotics help reduce the minimum inhibitory concentration (MIC) of each by four-fold or more. Synergistic combinations of antibiotics are useful when an infectious agent is unknown or when pathogens have populations of varying drug sensitivity, such as Mycobacterium tuberculosis.

Combining trimethoprim and sulfamethoxazole represents one of the most effective treatments for urinary tract infections. This combination works by inhibiting the activity of two different enzymes involved in the folate pathway, which block the synthesis of purines, the building blocks of DNA. The unavailability of purines impedes DNA synthesis, which ultimately kills the bacteria. Other antibiotic combinations use cell wall-active drugs, such as penicillins, which enhance the permeability of drugs, combined with aminoglycosides, which act on intracellular targets, like 30S ribosomes. These combinations prove highly effective in treating such infections as bacterial endocarditis caused by Enterococcal endocarditis.

In addition, some drugs do not have their own effects but potentiate the effect of other drugs in combination. One useful interaction is between β-lactamase inhibitors such as clavulanic acid and β-lactamase susceptible penicillins. Antibiotics such as penicillins and cephalosporins have β-lactam rings. The bacterial β-lactamase enzyme hydrolyses these rings, making these drugs inactive and leading to the emergence of antibiotic resistance. Using β-lactamase inhibitors and such antibiotics helps overcome the resistance that these bacterial enzymes generate.

Tags
SynergismSupra additive InteractionsTherapeutic EffectDrug CombinationsMinimum Inhibitory Concentration MICTrimethoprimSulfamethoxazoleUrinary Tract InfectionsFolate PathwayDNA SynthesisPenicillinsAminoglycosidesBacterial EndocarditisClavulanic AcidAntibiotic Resistance

来自章节 4:

article

Now Playing

4.15 : Combined Effects of Drugs: Synergism

Pharmacodynamics

3.1K Views

article

4.1 : 药物作用原则

Pharmacodynamics

5.5K Views

article

4.2 : 药物作用的目标:概述

Pharmacodynamics

5.2K Views

article

4.3 : 信号转导:概述

Pharmacodynamics

8.0K Views

article

4.4 : 换能器机制:G 蛋白偶联受体

Pharmacodynamics

1.7K Views

article

4.5 : 配体门控离子通道受体:门控机制

Pharmacodynamics

2.0K Views

article

4.6 : 换能器机制:酶联受体

Pharmacodynamics

2.2K Views

article

4.7 : 换能器机制:核受体

Pharmacodynamics

1.2K Views

article

4.8 : 剂量-反应关系:概述

Pharmacodynamics

2.7K Views

article

4.9 : 剂量-反应关系:效力和疗效

Pharmacodynamics

4.0K Views

article

4.10 : 剂量-反应关系:选择性和特异性

Pharmacodynamics

6.1K Views

article

4.11 : 治疗指数

Pharmacodynamics

3.9K Views

article

4.12 : 药物-受体相互作用:激动剂

Pharmacodynamics

2.2K Views

article

4.13 : 药物-受体相互作用:拮抗剂

Pharmacodynamics

2.4K Views

article

4.14 : 药物的综合作用:拮抗作用

Pharmacodynamics

7.5K Views

See More

JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。